BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30262185)

  • 1. ALK-rearranged inflammatory myofibroblastic tumour of placental membranes.
    Squires L; Matsika A; Turner J; Fitness J; Lourie R
    Pathology; 2018 Dec; 50(7):777-779. PubMed ID: 30262185
    [No Abstract]   [Full Text] [Related]  

  • 2. ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin.
    Schoolmeester JK; Sukov WR
    Int J Gynecol Pathol; 2017 May; 36(3):228-229. PubMed ID: 27636888
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
    Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
    Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
    Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
    Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
    Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Myofibroblastic Tumor of the Placenta: A Report of a Novel Lesion in 2 Patients.
    Banet N; Ning Y; Montgomery EA
    Int J Gynecol Pathol; 2015 Sep; 34(5):419-23. PubMed ID: 26262452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory myofibroblastic tumour of the testis with confirmed anaplastic lymphoma kinase gene rearrangement.
    Hickman RA; Alexander M; Provet J; Melamed J; Deng FM
    Histopathology; 2016 Jun; 68(7):1109-11. PubMed ID: 26444540
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Myofibroblastic Tumor Associated With the Placenta: Short Tandem Repeat Genotyping Confirms Uterine Site of Origin.
    Ladwig NR; Schoolmeester JK; Weil L; Chapman JS; Zaloudek C; Umetsu SE
    Am J Surg Pathol; 2018 Jun; 42(6):807-812. PubMed ID: 29505427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion.
    Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX
    Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
    Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
    Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion.
    Masuda Y; Tsukamoto Y; Zenitani M; Oda Y; Kinoshita I; Kohashi K; Takemoto J; Hirota S; Shibata A; Koda T; Takeshima Y
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27902. PubMed ID: 31250485
    [No Abstract]   [Full Text] [Related]  

  • 13. Xp11.2 translocation renal carcinoma with placental metastasis: a case report.
    Bovio IM; Allan RW; Oliai BR; Hampton T; Rush DS
    Int J Surg Pathol; 2011 Feb; 19(1):80-3. PubMed ID: 19164407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases.
    Makhdoum S; Nardi V; Devereaux KA; Kunder CA; Nielsen GP; Oliva E; Young RH; Roberts DJ
    Hum Pathol; 2020 Dec; 106():62-73. PubMed ID: 32971128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cutaneous inflammatory myofibroblastic tumour with ALK rearrangement in the upper extremity.
    Cantile M; Aquino G; Franco R; Marra L; Gallo M; De Chiara A
    Pathology; 2014 Oct; 46(6):575-6. PubMed ID: 25158817
    [No Abstract]   [Full Text] [Related]  

  • 16. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
    Chen ST; Lee JC
    Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.
    Sokai A; Enaka M; Sokai R; Mori S; Mori S; Gunji M; Fujino M; Ito M
    Jpn J Clin Oncol; 2014 Jan; 44(1):93-6. PubMed ID: 24277751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of a Pregnant Woman Diagnosed as Having
    Komura M; Yagishita S; Nakamura K; Arano N; Takeshige T; Muraki K; Nagashima O; Izumi H; Tomita S; Sasaki S; Takahashi K
    In Vivo; 2018; 32(5):1205-1209. PubMed ID: 30150445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
    Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
    Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary intraplacental gestational choriocarcinoma: histologic and genetic analyses.
    Kanehira K; Starostik P; Kasznica J; Khoury T
    Int J Gynecol Pathol; 2013 Jan; 32(1):71-5. PubMed ID: 23202784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.